.
BioEnterprise

Abeona Therapeutics

Abeona Therapeutics (NASDAQ: ABEO) is an early-stage biotechnology company focused on developing therapies for the deadly childhood genetic diseases Sanfilippo (SF) Syndrome Type A and Type B. The company’s two lead products, ABX-A and ABX-B, uniquely deliver the therapeutic product to the central nervous system with the aim of reversing the effects of the genetic errors that cause the disease.

Funding

Cure Sanfilippo Foundation, Sanfilippo Research Foundation (SRF), Team Sanfilippo, Abby Grace Foundation, National MPS Society, Stop Sanfilippo and Sanfilippo B Foundation (Spain), Foundation Sanfilippo (Switzerland), Red Sanfilippo Foundation (Mexico), Soros Fund Management, Perspective Life Science Fund

Stage

Clinical